The Board has approved ? 2 per share dividend.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Coral Laboratories Ltd reported audited financial results for FY2026 ended March 31, 2026. Total income declined to ₹9,579.68 lakhs from ₹12,411.39 lakhs in FY2025, while profit before tax fell to ₹2,311.49 lakhs from ₹3,247.02 lakhs. EPS for FY2026 stood at ₹45.85 versus ₹67.61 in the previous year. The Board recommended a final dividend of ₹2 per equity share (20% on face value of ₹10), subject to shareholder approval at the upcoming AGM. The company also appointed M/s S K Doshi & Associates as Internal Auditor and M/s Aatish Dhatrak & Associates as Cost Auditor for FY2026-2027.
Despite a significant year-on-year decline in revenue and profits, the company has maintained its dividend payout, which should provide some support to investor sentiment. However, the declining profitability trend may raise concerns about the sustainability of future dividends.